Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New alpha2C-adrenoceptor agonists display antinociceptive effects and cardiovascular safety in vivo

Sep. 9, 2010

Oral JNJ-41876666 is active against cold allodynia in models of neuropathic pain

Sep. 9, 2010

Rivaroxaban is as effective as standard therapy in treating deep vein thrombosis

Sep. 9, 2010

AZ-004 is efficacious in preclinical model of inflammatory pain

Sep. 9, 2010

BNC-210 is well tolerated in healthy volunteers

Sep. 9, 2010

Ivabradine improves outcome of patients with heart failure in SHIFT trial

Sep. 8, 2010

Italian scientists synthesize new HDAC inhibitor

Sep. 8, 2010

Technetium-99m-labeled MIP-1340 shows suitability for prostate cancer imaging

Sep. 8, 2010

Amantadine and fluoxetine display comparable efficacy in major depressive disorder

Sep. 8, 2010

Prucalopride is safe and efficacious in opioid-induced constipation

Sep. 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.